RECENT PUBLICATIONS
Treatment of Triple-Negative Breast Cancer Cells with the Canady Cold Plasma Conversion System: Preliminary Results
X. Cheng, W. Rowe, L. Ly, A. Shashurin, T. Zhuang, S. Wigh, G. Basadonna, B. Trink, M. Keidar and J. Canady
Plasma 2018, 1, 218–228; doi:10.3390/plasma1010019
A New Cold Plasma Jet: Performance Evaluation of Cold Plasma, Hybrid Plasma and Argon Plasma Coagulation
L. Ly, S. Jones, A. Shashurin, T. Zhuang, W. Rowe III, X. Cheng, S. Wigh, T. Naab, M. Keidar and J.Canady
Plasma 2018, 1, 189–200; doi:10.3390/plasma1010017
The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner
W. Rowe, X. Cheng, L. Ly, T. Zhuang, G. Basadonna, B. Trink, M. Keidar and J. Canady
Plasma 2018, 1, 177–188; doi:10.3390/plasma1010016
RECENT VIDEOS
The Canady Robotic Assisted SR-70 Surgical System #1
We are the Future
family of companies
The Canady Robotic Assisted SR-70 Surgical System #2
Cold Plasma Oncotherapeutics
doctor testimonials
VIEW USMI’s EDUCATIONAL AND CLINICAL VIDEO LIBRARY
LATEST POSTS
Thank you from the US Medical Innovations Team. #ACSCC18
what’s next? SUBSCRIBE
Keep up-to-date with the latest news at US Medical Innovations
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.
